本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011911 Size: 5 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011909 Size: 5 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001683168-23-001075 Act: 34 Size: 342 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-010876 Size: 5 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 8.01 Accession Number: 0001683168-23-000781 Act: 34 Size: 197 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-23-009116 Act: 34 Size: 67 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001683168-23-000307 Act: 34 Size: 247 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001683168-23-000098 Act: 34 Size: 1 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-22-008584 Act: 34 Size: 224 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061471 Size: 4 KB 网页链接